Journal of Infectious Diseases – Medicine Journal Guide for Researchers

Why Researchers Choose Journal of Infectious Diseases for High-Impact Publications

The Journal of Infectious Diseases stands as a cornerstone in the field of infectious diseases research, providing a platform for groundbreaking studies that advance medical science. Established in 1904 by the Infectious Diseases Society of America and published by Oxford University Press, this journal has evolved into a globally recognized resource for clinicians, microbiologists, and epidemiologists. Its rigorous peer-review process ensures that only high-quality, innovative research reaches publication, making it a preferred choice for authors seeking to influence clinical practice and public health policy.

Researchers are drawn to the Journal of Infectious Diseases for its comprehensive coverage of topics ranging from viral and bacterial pathogenesis to host immune responses and antimicrobial resistance. The journal's commitment to open science initiatives, including data sharing and transparency, further enhances its appeal in an era where reproducibility is paramount. With a focus on both basic and translational research, it bridges the gap between laboratory discoveries and real-world applications, such as vaccine development and outbreak management.

Publishing here not only amplifies an author's visibility but also connects them to a network of leading experts. The journal's archives offer invaluable insights into historical pandemics and emerging threats, serving as a reference for ongoing global health challenges. For academics navigating career progression, a publication in this venue signals expertise and dedication to the field.

As infectious diseases continue to pose significant threats worldwide, the Journal of Infectious Diseases remains at the forefront, fostering collaborations that drive progress. Whether exploring novel therapeutics or analyzing epidemiological trends, researchers find a supportive environment for their work. To explore opportunities in infectious disease academia, consider browsing medicine jobs or checking the academic calendar for upcoming conferences and deadlines.

Overview & History

The Journal of Infectious Diseases was founded in 1904 as the official publication of the Infectious Diseases Society of America (IDSA). Over the past century, it has chronicled pivotal advancements in understanding and combating infectious agents. From early reports on tuberculosis to contemporary analyses of COVID-19 variants, the journal has documented the evolution of medical knowledge in this domain.

Under Oxford University Press since 1974, it maintains a tradition of excellence while adapting to modern publishing standards. Its editorial team, led by Editor-in-Chief Martin S. Hirsch, MD, oversees a diverse portfolio that includes original articles, brief reports, and viewpoints. This historical depth makes it an essential archive for scholars studying the trajectory of infectious disease research.

Scope and Disciplines Covered

The journal encompasses a wide array of topics within infectious diseases, emphasizing interdisciplinary approaches. It publishes research on the etiology, pathogenesis, diagnosis, treatment, and prevention of infections caused by bacteria, viruses, fungi, and parasites.

DisciplineDescription
Infectious DiseasesCore focus on clinical and laboratory studies of infections.
MicrobiologyInvestigations into microbial genetics, virulence, and resistance.
ImmunologyHost-pathogen interactions and immune modulation.
EpidemiologyPopulation-level analysis of disease spread and control.
VirologyViral replication, evolution, and antiviral strategies.

Contributions must demonstrate novelty and relevance to human health, with an emphasis on translational potential.

Key Journal Metrics

MetricValueSource
Impact Factor (2022)5.3Clarivate Journal Citation Reports
5-Year Impact Factor5.2Clarivate JCR
Immediacy Index0.9Clarivate JCR
CiteScore8.4Scopus
h-Index292Scopus

These metrics reflect the journal's influence and citation frequency among peers.

Indexing and Abstracting

The Journal of Infectious Diseases is indexed in major databases, ensuring wide accessibility. Key services include PubMed/MEDLINE, Scopus, Web of Science, and Embase. This coverage facilitates discoverability and supports researchers in tracking citations. For global reach, it is also listed in DOAJ for open access articles and Sherpa/RoMEO for policy compliance.

Publication Model and Fees

As a hybrid journal, it offers both subscription-based and open access options. Authors can publish under a traditional model or choose gold open access with an Article Processing Charge (APC) of $4,104 USD. Waivers are available for corresponding authors from low-income countries. Page charges apply to non-OA articles at $100 per page.

Submission Process and Guidelines

Submissions are handled via the online portal at ScholarOne Manuscripts. Manuscripts must follow ICMJE guidelines, with a word limit of 3,000 for original articles. Ethical considerations, including IRB approval and conflict disclosures, are mandatory. The process involves initial screening, peer review, and revisions, typically taking 4-6 weeks for first decisions.

Editorial Board Highlights

The editorial board comprises distinguished experts from institutions worldwide. Editor-in-Chief Martin S. Hirsch, MD, from Massachusetts General Hospital, brings decades of experience in HIV and infectious disease therapeutics. Associate editors specialize in areas like mycology and parasitology, ensuring balanced oversight. Their expertise upholds the journal's high standards.

Why Publish in Journal of Infectious Diseases?

Publishing in the Journal of Infectious Diseases elevates a researcher's profile due to its prestige and readership of over 10,000 professionals. It accelerates career advancement by demonstrating impact in a competitive field. The journal's focus on timely topics, such as antimicrobial stewardship, aligns with funding priorities. Authors benefit from rapid dissemination and integration into clinical guidelines. For those in academia, it enhances grant applications and tenure dossiers. Explore related opportunities via higher ed jobs or PhD programs in medicine.

Comparison with Similar Journals

JournalImpact FactorPublisherFocus
Journal of Infectious Diseases5.3Oxford University PressBroad infectious diseases research
Clinical Infectious Diseases9.1Oxford University PressClinical and applied studies
The Lancet Infectious Diseases71.4ElsevierGlobal health and policy
Infection and Immunity3.5American Society for MicrobiologyMicrobial-host interactions
Emerging Infectious Diseases7.7CDCEmerging threats and epidemiology

This comparison highlights the Journal of Infectious Diseases' balanced position in scope and metrics.

Researcher Tips for Successful Submission

To maximize chances of acceptance, ensure your manuscript addresses a clear knowledge gap with robust methodology. Use concise language and high-quality figures. Engage with recent publications to contextualize your work. Pre-submission inquiries to the editorial office can provide guidance. Collaborate with co-authors experienced in the journal. Finally, proofread for compliance with author instructions. For career support, visit Rate My Professor or academic advising resources. Additional links: microbiology jobs, epidemiology careers, virology programs, immunology jobs, tenure-track positions, postdoc opportunities.

Frequently Asked Questions about Journal of Infectious Diseases

📈What is the current impact factor of the Journal of Infectious Diseases?

The 2022 impact factor is 5.3, according to Clarivate Journal Citation Reports. This metric underscores its influence in medicine. For career insights, check Rate My Professor.

📊What is the acceptance rate for submissions?

The acceptance rate is not publicly disclosed by the publisher. It is estimated around 20-25% based on peer benchmarks. Explore submission tips via academic advising.

💰What is the APC or open access policy?

As a hybrid journal, the APC for gold open access is $4,104 USD. Subscription access is available without fees for authors. Review policies on Sherpa/RoMEO. See PhD programs for funding ideas.

⏱️How long is the average review time?

The median time to first decision is 21 days, with full review averaging 4-6 weeks. This efficiency aids timely publications. Track deadlines with the academic calendar.

📝Where is the submission portal located?

Submissions are managed through ScholarOne at https://mc.manuscriptcentral.com/jid. Follow ICMJE guidelines for preparation. For related jobs, visit medicine jobs.

🔍Which databases index the Journal of Infectious Diseases?

It is indexed in PubMed/MEDLINE, Scopus, Web of Science, and Embase. This ensures broad visibility. Access via higher ed jobs library resources.

👨‍⚕️Who is the Editor-in-Chief?

Martin S. Hirsch, MD, from Massachusetts General Hospital, serves as Editor-in-Chief. His expertise in HIV research guides the journal. Learn more through Rate My Professor.

🚀How does publishing here benefit my career?

A publication boosts CVs for tenure, grants, and positions in infectious diseases. It signals high-impact work. Explore opportunities at tenure-track positions.

⚖️How does it compare to peer journals?

Compared to Clinical Infectious Diseases (IF 9.1), it offers broader basic research scope. Versus The Lancet ID (IF 71.4), it focuses more on lab studies. See comparisons in microbiology jobs contexts.